Back
Goldman Sachs S&P 500 Premium Income ETF Vs. Avidity Biosciences, Inc. Industry Stock Comparison
Sell
47
GPIX
Goldman Sachs S&P 500 Premium Income ETF
Last Price:
$52.33
Seasonality Move:
-0.32%
Buy
54
RNA
Avidity Biosciences, Inc.
Last Price:
$72.10
Seasonality Move:
29.53%
Sell
47
Goldman Sachs S&P 500 Premium Income ETF (GPIX)
is a Sell
Is Goldman Sachs S&P 500 Premium Income ETF a Buy, Sell or Hold?
-
The current Goldman Sachs S&P 500 Premium Income ETF [GPIX] share price is $51.88. The Score for GPIX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
GPIX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Avidity Biosciences, Inc. (RNA)
is a Buy
Is Avidity Biosciences, Inc. a Buy, Sell or Hold?
-
The current Avidity Biosciences, Inc. [RNA] share price is $71.87. The Score for RNA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
RNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GPIX Stock Price Chart
What is Goldman Sachs S&P 500 Premium Income ETF's stock price today?
-
The Goldman Sachs S&P 500 Premium Income ETF share price today is $51.88The current trend is moderately bearish and GPIX is experiencing selling pressure, which indicates risk of future bearish movement.
RNA Stock Price Chart
What is Avidity Biosciences, Inc.'s stock price today?
-
The Avidity Biosciences, Inc. share price today is $71.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.
GPIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 42.76 | Sell |
| Chaikin Money Flow: | -842174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.68 - 52.82) | Sell |
| Bollinger Bands (100): | (50.9 - 52.58) | Buy |
RNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.73 | Buy |
| Relative Strength Index (14 RSI): | 74.72 | Buy |
| Chaikin Money Flow: | -1245187 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.89 - 71.73) | Buy |
| Bollinger Bands (100): | (41.78 - 67.42) | Buy |
GPIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.53 | Sell |
| 20-day SMA: | 52.31 | Sell |
| 50-day SMA: | 52.3 | Sell |
| 200-day SMA: | 49.6 | Buy |
| 8-day EMA: | 52.4 | Sell |
| 20-day EMA: | 52.4 | Sell |
| 50-day EMA: | 52.19 | Sell |
| 200-day EMA: | 50.53 | Buy |
RNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.63 | Buy |
| 20-day SMA: | 71.44 | Buy |
| 50-day SMA: | 65.14 | Buy |
| 200-day SMA: | 42.57 | Buy |
| 8-day EMA: | 15.97 | Buy |
| 20-day EMA: | 6.84 | Buy |
| 50-day EMA: | 2.82 | Buy |
| 200-day EMA: | 0.72 | Buy |
Goldman Sachs S&P 500 Premium Income ETF Earnings Growth & GPIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences, Inc. Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.63 per share, and a decrease next year of $0.40 per share.
Goldman Sachs S&P 500 Premium Income ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Avidity Biosciences, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||